Integra Lifesciences Holdings Corp (IART)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$12.25
Buy
$12.39
$-0.64 (-4.97%)
Integra Lifesciences Holdings Corp is engaged in development, manufacturing, and marketing of product lines from its technology for applications ranging from burn and deep tissue wounds to repair of dura mater in the brain to repair of nerve and tendon.
Prices updated at 10 May 2025, 00:54 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Stuart M. Essig, PhD
CEO
Ms. Mojdeh Poul
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
4,396
Head office
1100 Campus Road
Princeton
United States
08540
Key personnel
| Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
|---|---|---|---|---|---|
Mr. Christian Stanton Schade Independent Director | 0.12m | - | - | 0.34m | - |
Dr. Jeffrey A. Graves Independent Director | 0.05m | - | - | 0.31m | - |
Ms. Barbara B. Hill Presiding Independent Director | 0.05m | - | - | 0.35m | - |
Dr. Keith Bradley,PhD Independent Director | 0.08m | - | - | 0.30m | - |
Mr. Stuart M. Essig, PhD Executive Chairman of the Board | 0.12m | - | - | 0.47m | - |
Mr. Raymond G. Murphy Independent Director | 0.08m | - | - | 0.30m | - |
Mr. Eric I. Schwartz Executive Vice President, Chief Legal Officer and Secretary | - | - | - | - | - |
Mr. Robert T. Davis, Jr Executive Vice President and President, Tissue Technologies | 0.54m | 0.13m | - | 2.26m | - |
Mr. Jeffrey A. Mosebrook Senior Vice President, Finance and Principal Accounting Officer | - | - | - | - | - |
Ms. Mojdeh Poul President, Chief Executive Officer and Director | - | - | - | - | - |
Mr. Michael McBreen Executive Vice President and President, Codman Specialty Surgical | 0.64m | 0.22m | - | 3.16m | - |
Ms. Shaundra D. Clay Independent Director | 0.08m | - | - | 0.30m | - |
Ms. Renee Wonlai Lo Independent Director | 0.08m | - | - | 0.30m | - |
Mr. Harvinder Singh Executive Vice President and President, International | 0.51m | 0.13m | - | 2.62m | - |
Ms. Lea Daniels Knight Executive Vice President and Chief Financial Officer | 0.62m | 0.28m | - | 3.15m | - |
Ms. Chantal Veillon-Berteloot Executive Vice President and Chief Human Resources Officer | - | - | - | - | - |
Top 5 shareholders
| Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 11,253,404 | - | 11253404 | - | 30 Apr 2025 | 14.58 |
| BlackRock Inc | 11,128,390 | 0.00511 | 242167 | 2.224527 | 30 Apr 2025 | 14.32 |
| Vanguard Group Inc. ( Junked) | 7,802,615 | - | 7802615 | - | 30 Apr 2025 | 10.11 |
| Vanguard Group Inc | 7,580,967 | 0.00299 | -162961 | -2.104371 | 30 Apr 2025 | 9.76 |
| BlackRock Fund Advisors | 7,519,148 | 3.28527 | -3296459 | - | 30 Apr 2025 | 9.68 |
Director dealings
| Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
|---|---|---|---|---|---|---|---|
| 03 Dec 2024 | - | Mr. Eric I. Schwartz | 24.59 | 100,102 | 59,511 | - | - |
| 02 Dec 2024 | - | Mr. Michael McBreen | 24.16 | 41,064 | 56,182 | - | - |
| 01 Sep 2024 | - | Ms. Chantal Veillon-Berteloot | 20.34 | 28,720 | 24,379 | - | - |
| 19 Aug 2024 | - | Mr. Jeffrey A. Mosebrook | 21.58 | 25,701 | 36,088 | - | - |
| 03 Jul 2024 | - | Ms. Lea Daniels Knight | 28.73 | 73,578 | 41,935 | - | - |
| 01 Jul 2024 | - | Mr. Jeffrey A. Mosebrook | - | - | 37,279 | - | - |
| 23 May 2024 | - | Mr. Stuart M. Essig, PhD | 28.49 | 1,499,979 | 487,922 | - | - |
| 21 May 2024 | - | Ms. Barbara B. Hill | 27.40 | 995,816 | 36,350 | - | - |
| 09 May 2024 | - | Mr. Christian Stanton Schade | - | - | 63,503 | - | - |
| 09 May 2024 | - | Dr. Jeffrey A. Graves | - | - | 12,494 | - | - |
| 09 May 2024 | - | Dr. Jeffrey A. Graves | - | - | 3,798 | - | - |
| 09 May 2024 | - | Ms. Barbara B. Hill | - | - | 100,322 | - | - |
| 09 May 2024 | - | Ms. Barbara B. Hill | - | - | 91,626 | - | - |
| 09 May 2024 | - | Dr. Keith Bradley,PhD | - | - | 70,175 | - | - |
| 12 May 2024 | - | Dr. Keith Bradley,PhD | 25.99 | 962 | 69,936 | - | - |
| 12 May 2024 | - | Dr. Keith Bradley,PhD | 25.99 | 5,250 | 69,973 | - | - |
| 09 May 2024 | - | Mr. Stuart M. Essig, PhD | - | - | 924,609 | - | - |
| 09 May 2024 | - | Mr. Stuart M. Essig, PhD | - | - | 935,281 | - | - |
| 09 May 2024 | - | Mr. Raymond G. Murphy | - | - | 54,007 | - | - |
| 09 May 2024 | - | Ms. Shaundra Clay | - | - | 21,923 | - | - |
Please note that past performance is not a reliable indicator of future returns.
